Scancell Holdings - User Ratings

These ratings are submitted by site users and should be used for information only. They do not constitute any instruction to trade and do not reflect the opinion of this site.

The colour of the lines on the chart indicate the performance of the rating based upon the price at the point the rating was submitted. More information »

BUY by Archimedes on 20 May 2014 07:50

Price at rating: 33.60, now:

A great buying opportunity in the run up to ASCO and the release of preliminary results for 8mg trial.

Score: 17.50

07:50:55 20 May 2014	33.60
08:51:03 20 May 2014	33.60
09:51:04 20 May 2014	33.60
10:51:04 20 May 2014	33.60
11:51:04 20 May 2014	33.68
12:51:05 20 May 2014	33.50
13:52:05 20 May 2014	33.50
14:53:09 20 May 2014	33.10
15:54:09 20 May 2014	33.10
08:16:14 21 May 2014	33.10
09:16:19 21 May 2014	33.10
10:17:03 21 May 2014	33.10
11:17:15 21 May 2014	33.15
12:18:15 21 May 2014	33.15
13:19:05 21 May 2014	33.00
14:20:15 21 May 2014	33.00
15:21:03 21 May 2014	33.00

BUY by Schlussel on 22 Feb 2014 13:19

Price at rating: 33.50, now:

The FDA's recent granting of Orphan Drug Designation to Scancell's lead cancer vaccine, SCIB1, massively increases the likelihood of a licensing deal in the near future.

Score: 78.75

13:19:00 22 Feb 2014	33.50
08:16:15 24 Feb 2014	33.50
09:17:44 24 Feb 2014	33.33
10:18:25 24 Feb 2014	33.33
11:19:12 24 Feb 2014	33.80
12:20:43 24 Feb 2014	33.80
13:21:19 24 Feb 2014	33.80
14:22:08 24 Feb 2014	33.80
15:23:08 24 Feb 2014	33.33
16:24:42 24 Feb 2014	33.70
08:16:07 25 Feb 2014	33.70
09:17:09 25 Feb 2014	33.90
10:18:04 25 Feb 2014	33.65
11:18:08 25 Feb 2014	34.00
12:19:31 25 Feb 2014	34.00
13:20:08 25 Feb 2014	33.98
14:21:12 25 Feb 2014	34.00

BUY by gudfella on 21 Jan 2014 20:18

Price at rating: 34.15, now:

moditope patent due 7th feb

Score: 47.50

20:18:58 21 Jan 2014	34.15
08:16:09 22 Jan 2014	34.15
09:17:01 22 Jan 2014	33.68
10:17:04 22 Jan 2014	34.92
11:18:34 22 Jan 2014	33.50
12:19:04 22 Jan 2014	33.50
13:20:03 22 Jan 2014	33.68
14:20:04 22 Jan 2014	34.90
15:21:01 22 Jan 2014	34.90
16:21:01 22 Jan 2014	34.88
08:16:06 23 Jan 2014	34.88
09:17:02 23 Jan 2014	33.80
10:17:02 23 Jan 2014	34.88
11:17:02 23 Jan 2014	34.77
12:18:02 23 Jan 2014	34.00
13:19:02 23 Jan 2014	34.00
14:21:02 23 Jan 2014	34.00

BUY by Schlussel on 10 Jan 2014 08:05

Price at rating: 29.77, now:

Scancell is expected to conclude licensing deals on both of its two cancer vaccine platforms. The shares will rise steeply when the first of these deals is announced. Getting in ahead of these deals while the shares are cheap makes a lot of sense.

Score: 100.00

08:05:45 10 Jan 2014	29.77
09:06:01 10 Jan 2014	29.84
10:06:01 10 Jan 2014	31.56
11:07:01 10 Jan 2014	31.56
12:08:02 10 Jan 2014	31.42
12:09:01 10 Jan 2014	31.42
13:10:02 10 Jan 2014	31.42
13:11:02 10 Jan 2014	31.42
08:16:03 13 Jan 2014	29.99
09:16:04 13 Jan 2014	32.08
10:17:03 13 Jan 2014	32.08
11:17:03 13 Jan 2014	31.63
12:17:03 13 Jan 2014	33.60
13:17:03 13 Jan 2014	32.00
14:17:04 13 Jan 2014	32.10
15:18:04 13 Jan 2014	32.02
16:19:01 13 Jan 2014	31.56

BUY by LadyBio on 08 Dec 2013 13:31

Price at rating: 30.41, now:

Are you kidding me? Because the Sunday Times has just leaked that Scancell's SCIB1 vaccine trials have proved successful. Seems that speculation is turning towards a possible licensing deal or an outright sale of the company. Either option would send these shares into orbit. Super STRONG BUY!r r [link]

Score: 100.00

13:31:03 8 Dec 2013	30.41
08:16:08 9 Dec 2013	36.50
09:17:06 9 Dec 2013	38.93
10:18:02 9 Dec 2013	37.90
11:18:07 9 Dec 2013	37.05
12:19:06 9 Dec 2013	37.40
13:20:05 9 Dec 2013	36.34
14:21:04 9 Dec 2013	36.55
15:22:03 9 Dec 2013	37.05
16:23:03 9 Dec 2013	37.00
08:16:04 10 Dec 2013	37.50
09:17:04 10 Dec 2013	36.66
10:18:03 10 Dec 2013	35.38
11:19:03 10 Dec 2013	36.14
12:20:03 10 Dec 2013	35.95
13:21:03 10 Dec 2013	35.80
14:22:03 10 Dec 2013	35.55